- Pharmacological studies on role of cAMP/cGMP-PDE inhibitors and their interactions with L-arginine & L-NAME in adjuvant induced rheumatoid arthritis in rats
R. Pal. Pharmacology & Therapeutics, King George's Medical University, UP, Lucknow, India
- Phencyclidine pretreatment abolishes the dopamine D4 mediated attenuation of nucleus accumbens dopamine release: Fast cyclic voltammetry studies in rat brain slices in vitro
A. Al-Ali1, A. Asif-Malik2, J. Canales3, A. M. Young1. 1Neuroscience, Psychology & Behaviour, University of Leicester, LEICESTER, United Kingdom, 2Pharmacology, University of Oxford, Oxford, United Kingdom, 3Psychology, University of Tasmania, Hobart, Australia
- Phosphodiesterase inhibitor as a target for cancer: a preliminary study modulating cAMP levels
D. Safitri1, F. Svensson2, I. Winfield1, M. Harris1, D. Bailey2, G. Ladds1. 1Pharmacology, University of Cambridge, Cambridge, United Kingdom, 2IOTA Pharmaceuticals Ltd, Cambridge, United Kingdom
- Physiological consequences of RAMP-mediated agonist bias at the calcitonin receptor-like receptor
A. J. Clark1, R. Thompson1, I. Winfield1, M. Wigglesworth2, G. Ladds1. 1University of Cambridge, Cambridge, United Kingdom, 2AstraZeneca, Macclesfield, Cheshire, United Kingdom
- Pinolenic acid co-activates free fatty acid receptors 1 and 4 and this signalling reduces GPR119 agonism in mouse colon mucosa
R. Moodaley1, M. Schindler2, D. M. Smith3, H. M. Cox1. 1Wolfson Centre for Age-Related Diseases, King's College London, London, United Kingdom, 2Innovative Medicines & Early Development, Cardiovascular & Metabolic Diseases iMed, AstraZeneca M”lndal, M”lndal, Sweden, 3Discovery Sciences, Innovative Medicines & Early Development Biotech Unit, AstraZeneca, Cambridge, United Kingdom
- Polypharmacy and the prescription of potentially inappropriate medicines in patients with COPD and co-morbidities
O. J. Mercer, E. H. Baker, S. McIvor, S. L. Kennie, H. K. Lamplough. St George's, University of London, London, United Kingdom
- Population pharmacokinetics of Trofinetide in paediatric Rett syndrome patients
S. P. Oosterholt1, N. E. Jones2, L. Glass2, O. Della Pasqua1. 1Clinical Pharmacology & Therapeutics, University College London, London, United Kingdom, 2Neuren Pharmaceuticals, Ltd, Port Melbourne, Australia
- Post-traumatic seizure prophylaxis in severe traumatic brain injury: a risk-benefit analysis.
M. Ardissino1, S. Muttoni1, A. Tang1, A. Faraj1, K. Tsang2. 1Imperial College London, London, United Kingdom, 2Department of Neurosurgery, Imperial College NHS Trust, Hammersmith, United Kingdom
- Preclinical evaluation of inhaled calcilytics as a potential anti-asthma therapy
P. L. Yarova1, P. Huang1, V. S. Telezhkin2, M. Schepelmann1, E. J. Kidd1, W. R. Ford1, K. J. Broadley1, J. P. Ward3, C. J. Corrigan3, P. J. Kemp1, D. Riccardi1. 1Cardiff University, Cardiff, United Kingdom, 2Newcastle University, Newcastle upon Tyne, United Kingdom, 3Kings College London, London, United Kingdom
- Pre-contraction with U46619 enhances the contraction to perivascular adipose tissue in porcine coronary artery: effect of statins.
T. Alsahli, R. Roberts, M. Randall. School of life sciences, University of Nottingham, Nottingham, United Kingdom
